Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12071485 Compositions and methods of treating facioscapulohumeral muscular dystrophy

Patent 12071485 was granted and assigned to Avidity Biosciences on August, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Avidity Biosciences

Current Assignee

Avidity Biosciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

120714850

Patent Inventor Names

Rob Burke0

David Sala Cano0

Barbora Malecova0

Beatrice Diana Darimont0

Date of Patent

August 27, 2024

Patent Application Number

184025960

Date Filed

January 2, 2024

Patent Citations

‌

US Patent 7132519 Releasable nonvolatile mass-label molecules

‌

US Patent 7244724 Pyrrolobenzodiazepines

‌

US Patent 7276497 Cytotoxic agents comprising new maytansinoids

‌

US Patent 7452987 Interfering RNA molecules

‌

US Patent 7498298 Monomethylvaline compounds capable of conjugation to ligands

‌

US Patent 7521232 Emissive species for clinical imaging

‌

US Patent 7528126 Pyrrolobenzodiazepines

‌

US Patent 7595387 Modified polynucleotides for reducing off-target effects in RNA interference

...

Patent Primary Examiner

‌

Ruixiang Li

Patent abstract

Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating facioscapulohumeral muscular dystrophy (FSHD).

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12071485 Compositions and methods of treating facioscapulohumeral muscular dystrophy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API